Literature DB >> 14707284

Cell cycle regulatory functions of the human oncoprotein MDM2.

Swati Palit Deb1.   

Abstract

The protein (MDM2) coded by the mouse double minute-2 (mdm2) gene or its human homologue is well known as an oncoprotein. Malignant human tumors particularly breast tumors and soft tissue sarcomas frequently overexpress MDM2. Artificial amplification of mdm2 gene derived from a transformed murine cell line enhances tumorigenic potential of murine cells. Consistent with its tumorigenic property, mouse or human MDM2 can inactivate several functions of the tumor suppressor p53 and can degrade p53. The protein also interacts with other tumor suppressors, and these interactions may contribute to its tumorigenic property. In spite of its oncogenic role, mouse or human MDM2 induces G(1) arrest in normal human or murine cells. Some cell lines bearing known genetic mutations are insensitive to MDM2-mediated growth arrest. This review is aimed to collect available information on the functions of MDM2 that could potentially regulate cell cycle and to discuss how this information may fit in one model that could explain the two apparently opposite G(1) arrest and oncogenic function of MDM2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14707284

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  39 in total

Review 1.  Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.

Authors:  Mu-Shui Dai; Yetao Jin; Jayme R Gallegos; Hua Lu
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

2.  Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma.

Authors:  Marcela K Hassumi-Fukasawa; Fabiana A Miranda-Camargo; Márcia C M Guimarães; Renata T Simões; Eduardo A Donadi; Christiane P Soares; Edson G Soares
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-05       Impact factor: 2.503

Review 3.  Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.

Authors:  C-Q Zhu; W Shih; C-H Ling; M-S Tsao
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

Review 4.  The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.

Authors:  James J Manfredi
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

5.  Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.

Authors:  Mu-Shui Dai; Dingding Shi; Yetao Jin; Xiao-Xin Sun; Yanping Zhang; Steven R Grossman; Hua Lu
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

Review 6.  Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1.

Authors:  Xiao-Xin Sun; Mu-Shui Dai
Journal:  World J Biol Chem       Date:  2014-05-26

7.  Influence of selected anti-cancer drugs on the induction of DNA double-strand breaks and changes in gene expression in human hepatoma HepG2 cells.

Authors:  Matjaž Novak; Bojana Žegura; Špela Baebler; Alja Štern; Ana Rotter; Katja Stare; Metka Filipič
Journal:  Environ Sci Pollut Res Int       Date:  2015-09-22       Impact factor: 4.223

8.  Splicing up mdm2 for cancer proteome diversity.

Authors:  Danielle R Okoro; Melissa Rosso; Jill Bargonetti
Journal:  Genes Cancer       Date:  2012-03

9.  Protecting the genome from mdm2 and mdmx.

Authors:  Alexia N Melo; Christine M Eischen
Journal:  Genes Cancer       Date:  2012-03

10.  The Expression of Murine Double Minute 2 (MDM2) on Helicobacter pylori-Infected Intestinal Metaplasia and Gastric Cancer.

Authors:  Noriko Nakajima; Yoko Ito; Kiyoshi Yokoyama; Akitake Uno; Noriko Kinukawa; Norimichi Nemoto; Mitsuhiko Moriyama
Journal:  J Clin Biochem Nutr       Date:  2009-02-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.